Matinas Biopharma (MTNB) vs Onconetix (ONCO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Onconetix is the larger company by market cap ($3.4 million vs $2.8 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MTNB | ONCO |
|---|---|---|
| Share price | $2.83 | $0.6543 |
| Market cap | $2.77M | $3.43M |
| 1-day change | +2.17% | +9.56% |
| P/E ratio (TTM) | — | 0.00 |
| EPS (TTM) | $-17.93 | $310.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $28.95 | $207.00 |
| 52-week low | $2.27 | $0.58 |
| Distance from 52-week high | -90.22% | -99.68% |
| Average volume | 408.10K | 2.96M |
| Shares outstanding | 979.52K | 5.24M |
| Employees | 2 | 2 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Matinas Biopharma
MTNB stock →Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides.
Healthcare · Biotechnology · 2 employees
About Onconetix
ONCO stock →Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.
Healthcare · Biotechnology · 2 employees
MTNB vs ONCO FAQ
Which is bigger, Matinas Biopharma or Onconetix?
Onconetix (ONCO) is larger, with a market capitalization of $3.43M compared with $2.77M for Matinas Biopharma (MTNB).
Are Matinas Biopharma and Onconetix in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.